Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pine Labs

UPI and AI: 'Buy Rs 500 worth gold if price drops below Rs 16,000/g'; your wish is AI agent's command, and it can make UPI payments at your target price

The P3P AI agent can complete a UPI payment without any human authentication. However, the human still stays in control. Currently, AI agents need a human authentication step, an MPIN, to make any payments. Pine Labs has removed this wall. It builds on UPI’s existing mandate framework - UPI One…

The Economic Times

Listed digital payment majors finally turn a corner in FY26

Growth in the core payments business, expansion across credit products and wider adoption of revenue-generating payment instruments like credit cards on UPI, helped payment companies strengthen their bottom lines.

The Economic Times

Ahead of Market: 10 things that will decide stock market action on Friday

Domestic equity benchmarks ended marginally lower for a second consecutive session as weakness in financial, IT and energy shares offset gains in auto stocks. Analysts expect Nifty to remain range-bound with immediate support near 23,800 and resistance around the 24,000-24,100 zone.

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Ahead of Market: 10 things that will decide stock market action on Wednesday

Domestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer stocks. Analysts said Nifty may remain positive above key support levels despite near-term weakness, while broader market sentiment stayed mixed with selective buying interest.

The Economic Times

Pine Labs shares rise over 4% after Q4 results. Why Morgan Stanley forecasts 67% upside

Pine Labs shares surged after the company reported a significant turnaround, posting a Rs 59 crore net profit in Q4FY26 against a loss last year. Full-year profits also swung to Rs 113 crore. Despite a recent share price dip, Morgan Stanley maintains an "Equal-weight" rating with a Rs 245 target,…

The Economic Times

Pine Labs Q4FY26: revenue up 17% to Rs 700 crore, net profit at Rs 59 crore

Pine Labs was listed in November 2025. Sharing details about its IPO proceeds, Pine Labs said that the company had raised Rs 2,080 crore in fresh capital, out of which around Rs 797 crore has already been used up with a major part going towards repaying borrowings.

The Economic Times

Pine Labs Q4 Results: Co turns to black, logs Rs 59 crore profit on 17% revenue jump

Pine Labs Q4 Results: Payments solutions provider Pine Labs turned profitable in the March-ended quarter, posting a consolidated net profit of Rs 59 crore versus a net loss of Rs 29 crore in the year ago period.

The Economic Times

Read news from The Economist, FT, and more,
with one subscription

Stocks in news: Suzlon Energy, Wipro, Hindalco, ICICI Bank, Eicher Motors

Indian markets closed with small gains amidst a volatile week. Investors will watch global economic news and policy comments. The RBI's dividend transfer will impact liquidity and government spending. Suzlon Energy, Wipro, Hindalco, ICICI Bank, and Eicher Motors are in focus. Companies like Suzlon Energy, RVNL, and Pine Labs will…

The Economic Times

Pine Labs shares crash 10% as IPO lock-in expiry frees up Rs 17,372 crore stake. Do you own?

Pine Labs shares saw a significant fall on Wednesday. This decline followed the expiry of a six-month lock-in period, which made a large number of shares available for trading. The stock reached its lowest point in over a month. This event does not guarantee immediate selling but opens the door…

The Economic Times

Pine Labs launches first batch for Second Innings

The scheme attempts to help retired athletes to enter the corporate world

The Hindu

Natekars focus on second innings

NSF joins hands with Pine Labs to help retired sports persons

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.